SCHEMBL9702835

SCHEMBL9702835

CSc1ccccc1-c1nc2cc3c(cc2[nH]1)C(C)(C)CC(=O)N3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
AURKA O14965 1/20 0.38
AURKB Q96GD4 1/20 0.38
ALOX5 P09917 1/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
ATM Q13315 1/20 0.37
ERAP1 Q9NZ08 1/20 0.37
KDM4E B2RXH2 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NPBWR1 P48145 2/20 0.35
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
GSK3B P49841 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9382509 0.83 PDE5A (0.46) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9378253 0.82 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9383800 0.81 PDE4A (0.50) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10699235 0.80 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9378130 0.79 KDM4E (0.52) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9385715 0.78 CBFB (0.54) NPC1RAB9AKDM4ENPSR1KMT2A
SCHEMBL9382393 0.78 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9380164 0.78 ESR1 (0.47) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9381958 0.78 GUSB (0.39) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9702847 0.77 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed